Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AllerT in Birch Pollen Allergy
NCT01728519Phase 2Terminated
- Sponsor
- Anergis
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cetirizine in birch pollen allergy, sponsored by Anergis. Started Aug 2008; status: terminated.
02
Drugs
cetirizine
03
Conditions
birch pollen allergy
Beyond the preview
Go deeper on NCT01728519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728519.